Antimetastasis gene expression and numerical chromosomal abnormalities of chromosomes 1 & 17 in serous tumours of the ovary

Citation
H. Kaya et al., Antimetastasis gene expression and numerical chromosomal abnormalities of chromosomes 1 & 17 in serous tumours of the ovary, EUR J GYN O, 22(3), 2001, pp. 240-242
Citations number
11
Categorie Soggetti
Reproductive Medicine
Journal title
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
ISSN journal
03922936 → ACNP
Volume
22
Issue
3
Year of publication
2001
Pages
240 - 242
Database
ISI
SICI code
0392-2936(2001)22:3<240:AGEANC>2.0.ZU;2-5
Abstract
Objective(s): The aim of this study was to examine the expression of the an timetastasis gene nm23 and numerical changes on chromosome 1 and 17 in ovar ian tumours. Methods: In this study 20 serous cystadenocarcinomas, ten borderline and fi ve benign tumours were analysed for expression of the nm23 antimetastasis g ene by immunohistochemistry and for numerical chromosomal abnormalities of chromosomes I and 17 by interphase cytogenetics. Results: Strong intracytoplasmic immunoreactivity with the antimetastasis g ene was observed in late stage carcinomas but not in benign or borderline t umours or in lymph node metastases. Numerical abnormalities were only obser ved in carcinomas. Conclusion(s): These sets of data are consistent with the majority of benig n and borderline tumours lacking invasive potential. Odds Ratio (OR) assess ment indicates that the presence of numerical aberrations correlates with i mmunopositivity.